4//SEC Filing
Garrett Gerald 4
Accession 0001209191-21-010262
CIK 0001094038other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:23 PM ET
Size
5.8 KB
Accession
0001209191-21-010262
Insider Transaction Report
Form 4
Garrett Gerald
Vice President, Clinical Ops.
Transactions
- Award
Employee Stock Option (right to buy)
2021-02-10+40,000→ 40,000 totalExercise: $3.29Exp: 2031-02-10→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a four year period commencing on March 10, 2021 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
Documents
Issuer
Marker Therapeutics, Inc.
CIK 0001094038
Entity typeother
Related Parties
1- filerCIK 0001804510
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:23 PM ET
- Size
- 5.8 KB